143 related articles for article (PubMed ID: 36910371)
21. Hepcidin and proinflammatory markers in children with chronic kidney disease: A case-control study
.
Goyal KK; Saha A; Sahi PK; Kaur M; Dubey NK; Goyal P; Upadhayay AD
Clin Nephrol; 2018 May; 89(5):363-370. PubMed ID: 29451472
[TBL] [Abstract][Full Text] [Related]
22. Frequency of iron deficiency anaemia in chronic kidney disease patient not on dialysis.
Kamil F; Dhrolia M; Hamid A; Qureshi R; Nasir K; Ahmad A
J Pak Med Assoc; 2022 Jul; 72(7):1396-1400. PubMed ID: 36156567
[TBL] [Abstract][Full Text] [Related]
23. Iron deficiency anaemia among apparently healthy pre-school children in Lagos, Nigeria.
Akodu OS; Disu EA; Njokanma OF; Kehinde OA
Afr Health Sci; 2016 Mar; 16(1):61-8. PubMed ID: 27358614
[TBL] [Abstract][Full Text] [Related]
24. Renal anemia and hydration status in non-dialysis chronic kidney disease: Is there a link?
Hildegard Stancu S; Stanciu A; Lipan M; Capusa C
J Med Life; 2018; 11(4):293-298. PubMed ID: 30894885
[No Abstract] [Full Text] [Related]
25. Evaluation of iron status in anemic pre-dialysis chronic kidney disease patients.
Waziri B; Babawale BT; Mabayoje MO
Niger J Clin Pract; 2022 Mar; 25(3):226-230. PubMed ID: 35295041
[TBL] [Abstract][Full Text] [Related]
26. Iron Status of Pregnant Women in Rural and Urban Communities of Cross River State, South-South Nigeria.
Okafor IM; Okpokam DC; Antai AB; Usanga EA
Niger J Physiol Sci; 2017 Mar; 31(2):121-125. PubMed ID: 28262847
[TBL] [Abstract][Full Text] [Related]
27. A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease.
Nickol AH; Frise MC; Cheng HY; McGahey A; McFadyen BM; Harris-Wright T; Bart NK; Curtis MK; Khandwala S; O'Neill DP; Pollard KA; Hardinge FM; Rahman NM; Armitage AE; Dorrington KL; Drakesmith H; Ratcliffe PJ; Robbins PA
BMJ Open; 2015 Jul; 5(7):e007911. PubMed ID: 26150144
[TBL] [Abstract][Full Text] [Related]
28. Iron Status of Cats with Chronic Kidney Disease.
Gest J; Langston C; Eatroff A
J Vet Intern Med; 2015; 29(6):1488-93. PubMed ID: 26417695
[TBL] [Abstract][Full Text] [Related]
29. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
30. Association between hepcidin, haemoglobin level and iron status in stage 4 chronic kidney disease patients with anaemia.
Mogadam RA; Nemati A; Amani F; Ghorbanihaghjo A; Argani H; Bashardoust B
J Pak Med Assoc; 2015 Apr; 65(4):354-7. PubMed ID: 25976565
[TBL] [Abstract][Full Text] [Related]
31. Iron Deficiency Anemia in Chronic Kidney Disease.
Gafter-Gvili A; Schechter A; Rozen-Zvi B
Acta Haematol; 2019; 142(1):44-50. PubMed ID: 30970355
[TBL] [Abstract][Full Text] [Related]
32. A 3-marker index improves the identification of iron disorders in CKD anaemia.
Mercadal L; Metzger M; Haymann JP; Thervet E; Boffa JJ; Flamant M; Vrtovsnik F; Gauci C; Froissart M; Stengel B;
PLoS One; 2014; 9(2):e84144. PubMed ID: 24586229
[TBL] [Abstract][Full Text] [Related]
33. Etiological spectrum of anemia in non-dialysis-dependent chronic kidney disease: A single-center study from India.
Vikrant S
Saudi J Kidney Dis Transpl; 2019; 30(4):932-942. PubMed ID: 31464252
[TBL] [Abstract][Full Text] [Related]
34. Electrocardiographic abnormalities among dialysis naïve chronic kidney disease patients in Ilorin Nigeria.
Chijioke A; Makusidi AM; Kolo PM
Ann Afr Med; 2012; 11(1):21-6. PubMed ID: 22199043
[TBL] [Abstract][Full Text] [Related]
35. Iron deficiency across chronic kidney disease stages: Is there a reverse gender pattern?
Aoun M; Karam R; Sleilaty G; Antoun L; Ammar W
PLoS One; 2018; 13(1):e0191541. PubMed ID: 29357391
[TBL] [Abstract][Full Text] [Related]
36. Increased NGAL level associated with iron store in chronic kidney disease with anemia.
Xiang D; Wang X; Liu P; Pan Y; Zhang Q; Chi X; Jing Y; Duan X; Wei Q; Wang J; Li M; Wang C
Clin Exp Med; 2018 Nov; 18(4):563-568. PubMed ID: 29909502
[TBL] [Abstract][Full Text] [Related]
37. Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial.
Macdougall IC; Bock AH; Carrera F; Eckardt KU; Gaillard C; Van Wyck D; Meier Y; Larroque S; Roger SD;
BMC Nephrol; 2017 Jan; 18(1):24. PubMed ID: 28095881
[TBL] [Abstract][Full Text] [Related]
38. Credibility of the measurement of serum ferritin and transferrin receptor as indicators of iron deficiency anemia in hemodialysis patients.
Mahdavi MR; Makhlough A; Kosaryan M; Roshan P
Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1158-62. PubMed ID: 22165676
[TBL] [Abstract][Full Text] [Related]
39. Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease.
Sheetz M; Barrington P; Callies S; Berg PH; McColm J; Marbury T; Decker B; Dyas GL; Truhlar SME; Benschop R; Leung D; Berg J; Witcher DR
Br J Clin Pharmacol; 2019 May; 85(5):935-948. PubMed ID: 30677788
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.
Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G
Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
